These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17400019)

  • 81. Diffusion abnormalities in the primary sensorimotor pathways in writer's cramp.
    Delmaire C; Vidailhet M; Wassermann D; Descoteaux M; Valabregue R; Bourdain F; Lenglet C; Sangla S; Terrier A; Deriche R; Lehéricy S
    Arch Neurol; 2009 Apr; 66(4):502-8. PubMed ID: 19364935
    [TBL] [Abstract][Full Text] [Related]  

  • 82. TENS is harmful in primary writing tremor.
    Meunier S; Bleton JP; Mazevet D; Sangla S; Grabli D; Roze E; Vidailhet M
    Clin Neurophysiol; 2011 Jan; 122(1):171-5. PubMed ID: 20634131
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Adult-onset primary focal foot dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Jan; 12(1):57-60. PubMed ID: 16154790
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Segmental dystonia following electrocution in childhood.
    Lim EC; Seet RC
    Neurol Sci; 2007 Mar; 28(1):38-41. PubMed ID: 17385094
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):264-70. PubMed ID: 17185301
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Treatment of writer's cramp and other forms of limb dystonias with botulinum toxin].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():45-50. PubMed ID: 9608552
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.
    Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE
    J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Primary focal dystonia: descriptive study of 205 patients].
    Bartolomé FM; Fanjul S; Cantarero S; Hernández J; García Ruiz PJ
    Neurologia; 2003 Mar; 18(2):59-65. PubMed ID: 12610754
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prospective clinical study of writer's cramp.
    Jedynak PC; Tranchant C; de Beyl DZ
    Mov Disord; 2001 May; 16(3):494-9. PubMed ID: 11391744
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.
    Wissel J; Kabus C; Wenzel R; Klepsch S; Schwarz U; Nebe A; Schelosky L; Scholz U; Poewe W
    J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):172-5. PubMed ID: 8708685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Temporal processing of visuotactile and tactile stimuli in writer's cramp.
    Fiorio M; Tinazzi M; Bertolasi L; Aglioti SM
    Ann Neurol; 2003 May; 53(5):630-5. PubMed ID: 12730997
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status.
    Molho ES; Agarwal N; Regan K; Higgins DS; Factor SA
    Mov Disord; 2009 Jul; 24(9):1384-7. PubMed ID: 19441129
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia.
    Skogseid IM; Røislien J; Claussen B; Kerty E
    Mov Disord; 2005 Dec; 20(12):1604-9. PubMed ID: 16114026
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience.
    Aquino CC; Felício AC; Castro PC; Oliveira RA; Silva SM; Borges V; Ferraz HB
    Arq Neuropsiquiatr; 2012 Sep; 70(9):662-6. PubMed ID: 22990720
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Adduction spastic dysphonia: clinical and treatment].
    García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J
    Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 98. White matter abnormalities in dystonia normalize after botulinum toxin treatment.
    Blood AJ; Tuch DS; Makris N; Makhlouf ML; Sudarsky LR; Sharma N
    Neuroreport; 2006 Aug; 17(12):1251-5. PubMed ID: 16951564
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impaired force control in writer's cramp showing a bilateral deficit in sensorimotor integration.
    Bleton JP; Teremetz M; Vidailhet M; Mesure S; Maier MA; Lindberg PG
    Mov Disord; 2014 Jan; 29(1):130-4. PubMed ID: 24123136
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Task-specific interhemispheric hypoconnectivity in writer's cramp - An EEG study.
    Thirugnanasambandam N; Zimmerman T; Pillai AS; Shields J; Horovitz SG; Hallett M
    Clin Neurophysiol; 2020 May; 131(5):985-993. PubMed ID: 32193164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.